You’re using a public version of DrugChatter with 1 free searches available. Register to unlock more free searches per day. CREATE FREE ACCOUNT

Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Has the global patent for tigecycline injection been extended?



The global patent for tigecycline injection has not been extended based on the provided sources. The information from Drug Patent Watch, the US Patent and Trademark Office, and the European Patent Office does not indicate any patent term extensions for tigecycline injection. Therefore, the patent for tigecycline injection remains unchanged as per the available data.

Sources:
[1] drugpatentwatch.com/p/tradename/TIGECYCLINE
[2] uspto.gov/patents/laws/patent-term-extension/patent-terms-extended-under-35-usc-156
[3] epo.org/en/boards-of-appeal/decisions/t121422eu1



Follow-up:   Are there any new developments with tigecycline injection? How does the extended patent for tigecycline injection impact pricing? What are the benefits of tigecycline injection over alternatives?





DrugPatentWatch - Make Better Decisions
© thinkBiotech LLC 2004 - 2024. All rights reserved.